Frank Takkinen
Stock Analyst at Lake Street
(1.97)
# 2,918
Out of 4,711 analysts
44
Total ratings
40%
Success rate
-8.2%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSPR InspireMD | Initiates: Buy | $5 | $3.00 | +66.67% | 1 | Dec 11, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $12 → $15 | $12.11 | +23.86% | 6 | Oct 30, 2024 | |
| NOTV Inotiv | Upgrades: Buy | $2 → $4 | $4.08 | -1.96% | 6 | Sep 30, 2024 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $11 → $15 | $15.55 | -3.51% | 3 | Aug 27, 2024 | |
| SGHT Sight Sciences | Initiates: Buy | $10 | $3.57 | +180.11% | 1 | Aug 21, 2024 | |
| CLBT Cellebrite DI | Maintains: Buy | $14 → $17 | $22.52 | -24.51% | 2 | Aug 16, 2024 | |
| TELA TELA Bio | Maintains: Buy | $14 → $8 | $2.85 | +180.70% | 2 | Aug 13, 2024 | |
| AORT Artivion | Maintains: Buy | $28 → $30 | $28.48 | +5.34% | 2 | Jul 2, 2024 | |
| ELUT Elutia | Maintains: Buy | $5 → $10 | $4.84 | +106.61% | 2 | Jun 21, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $12 | $6.15 | +95.12% | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.65 | +263.64% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.31 | +73.16% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $11.53 | +4.08% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $4.02 | -0.50% | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $305 → $350 | $187.77 | +86.40% | 1 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5 | $1.83 | +173.22% | 3 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $1.57 | +473.25% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.19 | +630.59% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.58 | +1,485.91% | 2 | Jan 18, 2023 |
InspireMD
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $3.00
Upside: +66.67%
CVRx, Inc.
Oct 30, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $12.11
Upside: +23.86%
Inotiv
Sep 30, 2024
Upgrades: Buy
Price Target: $2 → $4
Current: $4.08
Upside: -1.96%
ClearPoint Neuro
Aug 27, 2024
Maintains: Buy
Price Target: $11 → $15
Current: $15.55
Upside: -3.51%
Sight Sciences
Aug 21, 2024
Initiates: Buy
Price Target: $10
Current: $3.57
Upside: +180.11%
Cellebrite DI
Aug 16, 2024
Maintains: Buy
Price Target: $14 → $17
Current: $22.52
Upside: -24.51%
TELA Bio
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $2.85
Upside: +180.70%
Artivion
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $28.48
Upside: +5.34%
Elutia
Jun 21, 2024
Maintains: Buy
Price Target: $5 → $10
Current: $4.84
Upside: +106.61%
Pulmonx
Jun 4, 2024
Initiates: Buy
Price Target: $12
Current: $6.15
Upside: +95.12%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.65
Upside: +263.64%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.31
Upside: +73.16%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $11.53
Upside: +4.08%
Sep 7, 2023
Initiates: Buy
Price Target: $4
Current: $4.02
Upside: -0.50%
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $187.77
Upside: +86.40%
Jul 19, 2023
Maintains: Buy
Price Target: $2.5 → $5
Current: $1.83
Upside: +173.22%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $1.57
Upside: +473.25%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.19
Upside: +630.59%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.58
Upside: +1,485.91%